Alzheimer's disease

Innovative way to study Alzheimer's disease developed by Cambridge scientists.

A £1m brain-imaging study has just been launched at the University of Cambridge to investigate why people with Down’s syndrome (DS) are at such high...

A collaboration between virologists and neuroscientists at Cambridge University has demonstrated how viruses that cross the blood/brain barrier could...

World’s leading researchers work together on therapeutic advances in neuroscience.

Launch of first ever rapid, objectively-scored GP assessment to differentiate between patients with memory loss due to the earliest signs of...

Innovation on the strength of a simple test identified in a new study would enable intervention before damage is done.

There are over 15 million people suffering from Alzheimer's disease globally and the current cost to the economy represents at least one per cent of...

A team of scientists from Cambridge and Sweden have discovered a molecule that can prevent a toxic protein involved Alzheimer's disease from building...